| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 肌肽系列(元) | 33,274,057.89 | 45,452,968.58 | 26,892,475.41 | 59,875,883.34 | 30,659,487.24 |
| 磷脂酰胆碱系列(元) | 13,322,335.84 | 41,094,282.41 | 25,228,033.05 | 41,617,500.06 | 19,315,727.03 |
| 硫辛酸系列(元) | 147,826,799.85 | 276,481,081.94 | 143,395,475.85 | 374,872,549.42 | 242,478,846.57 |
| 艾瑞昔布(元) | 26,591,184.08 | 62,978,472.56 | - | 6,735,265.48 | - |
| 营业成本(元) | |||||
| 肌肽系列(元) | 24,638,800.05 | 32,997,803.10 | 18,275,877.63 | 40,550,612.67 | 21,372,944.07 |
| 磷脂酰胆碱系列(元) | 11,036,637.24 | 25,045,029.75 | 15,722,144.33 | 28,299,325.45 | 13,745,485.75 |
| 硫辛酸系列(元) | 123,324,403.53 | 226,558,999.20 | 113,272,288.76 | 218,916,413.60 | 121,146,400.75 |
| 艾瑞昔布(元) | 20,837,284.92 | 55,928,462.04 | - | 6,531,894.80 | - |
| 毛利(元) | |||||
| 肌肽系列(元) | 8,635,257.84 | 12,455,165.48 | 8,616,597.78 | 19,325,270.67 | 9,286,543.17 |
| 磷脂酰胆碱系列(元) | 2,285,698.60 | 16,049,252.66 | 9,505,888.72 | 13,318,174.61 | 5,570,241.28 |
| 硫辛酸系列(元) | 24,502,396.32 | 49,922,082.74 | 30,123,187.09 | 155,956,135.82 | 121,332,445.82 |
| 艾瑞昔布(元) | 5,753,899.16 | 7,050,010.52 | - | 203,370.68 | - |
| 毛利率(%) | |||||
| 肌肽系列(%) | 25.95 | 27.40 | 32.04 | 32.28 | 30.29 |
| 磷脂酰胆碱系列(%) | 17.16 | 39.05 | 37.68 | 32.00 | 28.84 |
| 硫辛酸系列(%) | 16.58 | 18.06 | 21.01 | 41.60 | 50.04 |
| 艾瑞昔布(%) | 21.64 | 11.19 | - | 3.02 | - |
| 收入构成(%) | |||||
| 肌肽系列(%) | 15.06 | 10.67 | 13.75 | 12.39 | 10.48 |
| 磷脂酰胆碱系列(%) | 6.03 | 9.65 | 12.90 | 8.61 | 6.60 |
| 硫辛酸系列(%) | 66.89 | 64.90 | 73.34 | 77.60 | 82.91 |
| 艾瑞昔布(%) | 12.03 | 14.78 | - | 1.39 | - |
| 毛利构成(%) | |||||
| 肌肽系列(%) | 20.97 | 14.57 | 17.86 | 10.24 | 6.82 |
| 磷脂酰胆碱系列(%) | 5.55 | 18.78 | 19.70 | 7.05 | 4.09 |
| 硫辛酸系列(%) | 59.50 | 58.40 | 62.44 | 82.60 | 89.09 |
| 艾瑞昔布(%) | 13.97 | 8.25 | - | 0.11 | - |